|
Records 1-4 (of 4 Records) |
| Query Trace: ERG[original query]>>ERG[Gene] |
|---|
| COVID-19 Drugs Chloroquine and Hydroxychloroquine, but Not Azithromycin and Remdesivir, Block hERG Potassium Channels. Szendrey Mark, et al. The Journal of pharmacology and experimental therapeutics 2021 3 0. 
|
| Off-label use of chloroquine, hydroxychloroquine, azithromycin and lopinavir/ritonavir in COVID-19 risks prolonging the QT interval by targeting the hERG channel. Zequn Zheng, et al. European journal of pharmacology 2020 12 0. 173813
|
| Gene of the month: TMPRSS2 (transmembrane serine protease 2). Thunders Michelle, et al. Journal of clinical pathology 2020 9 0.
|
| Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N = 4532). Montopoli M, et al. Annals of oncology : official journal of the European Society for Medical Oncology 2020 5 0.
|
Disclaimer: Articles listed in the Public Health
Knowledge Base are selected by the CDC Office of Public Health
Genomics to provide current awareness of the literature and news.
Inclusion in the update does not necessarily represent the views of
the Centers for Disease Control and Prevention nor does it imply
endorsement of the article's methods or findings. CDC and DHHS assume
no responsibility for the factual accuracy of the items presented. The
selection, omission, or content of items does not imply any
endorsement or other position taken by CDC or DHHS. Opinion, findings
and conclusions expressed by the original authors of items included in
the update, or persons quoted therein, are strictly their own and are
in no way meant to represent the opinion or views of CDC or DHHS.
References to publications, news sources, and non-CDC Websites are
provided solely for informational purposes and do not imply
endorsement by CDC or DHHS.
- Page last reviewed:Oct 1, 2021
- Page last updated:Jul 02, 2022
- Content source: